Acquiring Company
LuminUltra
Acquired Company
Genomadix
Description
LuminUltra, the global leader in applied molecular diagnostics, has acquired the legionella testing business assets of Genomadix Inc. This strategic acquisition broadens LuminUltra's portfolio of molecular testing solutions, enabling rapid identification and quantification of microbes in water systems. It also empowers LuminUltra to develop and commercialize additional assays and test methods globally using the Genomadix Cube™ qPCR Platform.
Quick answer
LuminUltra is acquiring Genomadix, announced September 9, 2024. LuminUltra is based in Fredericton, New Brunswick, Canada.
- How much did LuminUltra pay for Genomadix?
- The deal value was not disclosed.
- What does LuminUltra do?
- LuminUltra is a global leader in applied molecular diagnostics, operating at the nexus of food, energy and water systems.
- Where are LuminUltra and Genomadix based?
- LuminUltra is based in Fredericton, New Brunswick, Canada. Genomadix is based in Ottawa, Ontario, Canada.
- Who are the decision-makers at LuminUltra?
- Fundz holds 1 contact at LuminUltra. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Water and research
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
- Trudell Medical Limited to acquire Vyaire Medical RDx, expanding into respiratory diagnostics (August 22, 2024)
- Merck completes acquisition of Modifi Biosciences, Inc. to advance DNA modification enabled cancer therapeutics (October 23, 2024)
- Access Genetics dba OralDNA® Labs acquires Breakthrough Point-of-Care Rapid PCR Technology from Sensible Diagnostics Inc. (October 22, 2024)
Who to call at LuminUltra, and when
When LuminUltra changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LuminUltra raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LuminUltra, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LuminUltra. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LuminUltra makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Genomadix?
Genomadix was acquired by LuminUltra, based in Fredericton. The deal was reported on September 9, 2024. LuminUltra is a global leader in applied molecular diagnostics, operating at the nexus of food, energy and water systems. LuminUltra is privately held and operates in Health Care.
When did LuminUltra acquire Genomadix?
LuminUltra's acquisition of Genomadix was reported on September 9, 2024. LuminUltra, the global leader in applied molecular diagnostics, has acquired the legionella testing business assets of Genomadix Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Genomadix do?
Genomadix Inc. is a pioneer in real-time qPCR point of need technology. It is based in Ottawa, Canada, and specializes in molecular diagnostic instruments for precision medicine genotyping. It is privately held, operating in Biotechnology, and is based in Ottawa.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.